As the end of the Transition Period on 31st December 2020 draws ever closer, pharmaceutical companies are preparing for life outside the EU Single Market and Customs Union. Holding additional stock could provide a buffer against any potential border disruption that could occur during the transition to the controls that will be implemented on 1st January 2021.
Recent advice from the Department of Health and Social Care suggests that companies make stockpiling a key part of contingency planning. If you are planning to hold additional stock in line with this recommendation, we can offer MHRA regulated warehouse space for storing products in the UK available now. We can also provide fully temperature-controlled transportation for next day delivery that is aligned to GDP.